PAK4: a pluripotent kinase that regulates prostate cancer cell adhesion.
Hepatocyte growth factor (HGF) is associated with tumour progression and increases the invasiveness of prostate carcinoma cells. Migration and invasion require coordinated reorganisation of the actin cytoskeleton and regulation of cell-adhesion dynamics. Rho-family GTPases orchestrate both of these cellular processes. p21-activated kinase 4 (PAK4), a specific effector of the Rho GTPase Cdc42, is activated by HGF, and we have previously shown that activated PAK4 induces a loss of both actin stress fibres and focal adhesions. We now report that DU145 human prostate cancer cells with reduced levels of PAK4 expression are unable to successfully migrate in response to HGF, have prominent actin stress fibres, and an increase in the size and number of focal adhesions. Moreover, these cells have a concomitant reduction in cell-adhesion turnover rates. We find that PAK4 is localised at focal adhesions, is immunoprecipitated with paxillin and phosphorylates paxillin on serine 272. Furthermore, we demonstrate that PAK4 can regulate RhoA activity via GEF-H1. Our results suggest that PAK4 is a pluripotent kinase that can regulate both actin cytoskeletal rearrangement and focal-adhesion dynamics.
Wells
Claire M
CM
Division of Cancer Studies, New Hunts House, Guy's Campus, King's College London, London SE1 1UL, UK. claire.wells@kcl.ac.uk
Whale
Andrew D
AD
Parsons
Maddy
M
Masters
John R W
JR
Jones
Gareth E
GE
D002448:Cell Adhesion / Q000187:drug effects; D045744:Cell Line, Tumor; D002465:Cell Movement / Q000187:drug effects; D022001:Focal Adhesions / Q000378:metabolism* / Q000473:pathology; D015972:Gene Expression Regulation, Neoplastic; D020662:Guanine Nucleotide Exchange Factors / Q000378:metabolism; D017228:Hepatocyte Growth Factor / Q000378:metabolism; D006801:Humans; D008297:Male; D051419:Paxillin / Q000378:metabolism; D010766:Phosphorylation / Q000187:drug effects; D011471:Prostatic Neoplasms / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D011485:Protein Binding / Q000187:drug effects; D064067:Rho Guanine Nucleotide Exchange Factors; D054462:p21-Activated Kinases / Q000494:pharmacology*; D020742:rhoA GTP-Binding Protein / Q000378:metabolism
C577356:ARHGEF2 protein, human; D020662:Guanine Nucleotide Exchange Factors; D051419:Paxillin; D064067:Rho Guanine Nucleotide Exchange Factors; D017228:Hepatocyte Growth Factor; C116367:PAK4 protein, human; D054462:p21-Activated Kinases; D020742:rhoA GTP-Binding Protein
J Cell Biol. 2006 May 22;173(4):587-9
16717130
Cell Signal. 2000 Aug;12(8):515-24
11027944
Trends Cell Biol. 2008 May;18(5):210-9
18394899
Cell Signal. 2008 Jul;20(7):1320-8
18424072
Development. 2008 May;135(10):1771-80
18403410
Tumour Biol. 2008;29(1):41-9
18497548
Am J Pathol. 2001 Aug;159(2):579-90
11485916
J Cell Sci. 2008 Aug 1;121(Pt 15):2435-44
18650496
J Cell Sci. 2002 Oct 15;115(Pt 20):3947-56
12244132
Mol Cell Biol. 2003 Oct;23(20):7122-33
14517283
Cell Motil Cytoskeleton. 2005 Nov;62(3):180-94
16211585
J Biol Chem. 2004 Apr 30;279(18):18392-400
14970201
Mol Cancer Res. 2008 Jul;6(7):1215-24
18644984
Methods Enzymol. 2000;325:264-72
11036609
Curr Opin Cell Biol. 2000 Feb;12(1):133-9
10679361
Nat Cell Biol. 2000 Dec;2(12):E231-6
11146675
Cell Signal. 2009 Dec;21(12):1738-47
19628037
Mol Biol Cell. 2009 Sep;20(18):4070-82
19625450
Dev Cell. 2007 May;12(5):699-712
17488622
Int J Biochem Cell Biol. 2008;40(11):2397-409
18485788
FEBS Lett. 2008 Jun 18;582(14):2093-101
18460342
Nat Cell Biol. 2002 Apr;4(4):294-301
11912491
Mol Cell Biol. 2009 Jun;29(11):3018-32
19289496
Proc Natl Acad Sci U S A. 2008 Dec 9;105(49):19372-7
19050074
Mol Biol Cell. 2000 May;11(5):1709-25
10793146
Curr Biol. 2003 Feb 18;13(4):R128-30
12593812
Prostate. 2002 May 1;51(2):98-107
11948964
Cancer Metastasis Rev. 2009 Jun;28(1-2):51-63
19165420
J Biol Chem. 2008 Sep 5;283(36):24949-61
18586681
Cancer Res. 2006 Dec 15;66(24):11700-8
17178865
Biochem J. 2009 Feb 15;418(1):173-84
18986306
J Cell Biol. 2008 Jan 14;180(1):187-203
18195107
Mol Cell Biol. 2000 Sep;20(17):6354-63
10938112
J Cell Physiol. 2003 Jul;196(1):196-205
12767056
J Cell Sci. 2002 May 1;115(Pt 9):1985-93
11956329
Nature. 2008 Dec 18;456(7224):957-61
19078960
Biol Cell. 2008 Feb;100(2):97-108
18199048
Science. 2003 Dec 5;302(5651):1704-9
14657486
Prostate. 1999 Nov 1;41(3):145-53
10517872
Nat Cell Biol. 2007 Aug;9(8):858-67
17671451
Nature. 2005 Aug 11;436(7052):792
16094359
J Biol Chem. 2004 Feb 13;279(7):6182-9
14625312
J Biol Chem. 2001 Nov 23;276(47):43987-93
11535592
J Cell Sci. 2005 May 1;118(Pt 9):1861-72
15827085
Am J Physiol Lung Cell Mol Physiol. 2006 Mar;290(3):L540-8
16257999
J Cell Biol. 2002 Sep 30;158(7):1287-97
12356872
Mol Biol Cell. 2008 Oct;19(10):4442-53
18653465
Cancer Res. 1997 Mar 1;57(5):995-1002
9041206
J Biol Chem. 2002 Jan 4;277(1):550-8
11668177
Eur J Biochem. 1996 Dec 1;242(2):171-85
8973630
EMBO J. 1998 Nov 16;17(22):6527-40
9822598
Biochem Biophys Res Commun. 2001 Aug 3;285(5):1330-7
11478803
Cancer Biol Ther. 2008 Nov;7(11):1793-802
18836286
Curr Biol. 2006 Dec 5;16(23):2337-44
17141616
J Microsc. 2008 Oct;232(1):73-81
19017203